filmov
tv
Future directions in T-cell lymphoma
Показать описание
Matko Kalac, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses future directions in T-cell lymphoma, highlighting a study investigating the use of romidepsin and azacitidine versus investigator's choice, and further commenting on the potential use of CAR-T therapy and other novel agents. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
0:00:56
0:16:24
0:01:05
0:01:35
0:01:40
0:04:25
0:02:15
0:02:08
0:15:26
0:03:55
0:01:00
0:07:10
0:03:12
0:06:38
0:05:03
0:02:57
0:01:29
0:01:45
0:55:05
0:01:25
0:27:06
0:04:14
0:50:48
0:03:04